[Progressive hypertelorism secondary to craniofacial plasmocytoma].
De Lucas
Gemma
G
Servicio de Otorrinolaringología, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, España. gemmadelucas@yahoo.es
Arias
Francisco
F
Redondo
Francisco
F
De Bonis
Mario
M
D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003287:Contrast Media; D016371:Cranial Irradiation; D003907:Dexamethasone / Q000008:administration & dosage; D005004:Ethmoid Bone / Q000000981:diagnostic imaging / Q000473:pathology*; D005260:Female; D005624:Frontal Bone / Q000000981:diagnostic imaging / Q000473:pathology*; D005682:Gadolinium; D006801:Humans; D006972:Hypertelorism / Q000209:etiology*; D007147:Immunoglobulin Light Chains / Q000032:analysis; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010954:Plasmacytoma / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy; D011719:Pyrazines / Q000008:administration & dosage; D012888:Skull Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000532:radiotherapy; D014057:Tomography, X-Ray Computed
D001897:Boronic Acids; D003287:Contrast Media; D007147:Immunoglobulin Light Chains; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D005682:Gadolinium